Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Cytokinetics (CYTK) Other Gross PP&E Adjustments (2016 - 2025)

Cytokinetics (CYTK) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $50.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments changed N/A to $50.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $50.5 million for FY2025, N/A changed from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $50.5 million at Cytokinetics, up from -$77.6 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $50.5 million in Q4 2025, with the low at -$83.0 million in Q2 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$56.2 million, with a median of -$77.2 million recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments crashed 53.45% in 2021, then rose 22.28% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $16.3 million in 2021, then decreased by 9.26% to $14.8 million in 2022, then increased by 22.28% to $18.1 million in 2023, then tumbled by 521.58% to -$76.3 million in 2024, then skyrocketed by 166.17% to $50.5 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $50.5 million, -$77.6 million, and -$76.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.